A rationale for antiparasite drug discovery
- 1 January 1994
- journal article
- Published by Elsevier in Parasitology Today
- Vol. 10 (10) , 385-386
- https://doi.org/10.1016/0169-4758(94)90227-5
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Pharmacokinetic Considerations in Rational Drug DesignClinical Pharmacokinetics, 1994
- Biochemistry of benzimidazole resistanceActa Tropica, 1994
- Gene transfer and antisense nucleic acid techniquesParasitology Today, 1994
- Ivermectin resistanceParasitology Today, 1993
- Substrate interactions between trypanothione reductase and N1‐glutathionylspermidine disulphide at 0.28‐nm resolutionEuropean Journal of Biochemistry, 1993
- Structure-Based Discovery of Inhibitors of Thymidylate SynthaseScience, 1993
- Lack of effect of desipramine on the response to chloroquine of patients with chloroquine-resistant falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1992
- Generation and use of synthetic peptide combinatorial libraries for basic research and drug discoveryNature, 1991
- The metabolic basis for combination chemotherapyPharmacology & Therapeutics, 1988
- Philosophy of new drug discovery.Microbiological Reviews, 1986